Use of subcutaneous immunoglobulin in stiff person syndrome: Case series

Keyphrases

• Stiff Person Syndrome 100%
• Subcutaneous Immunoglobulin 100%
• Intravenous Immunoglobulin (IVIg) 33%
• Spasm 13%
• Glutamic Acid Decarboxylase 65 (GAD65) 13%
• Tolerability 6%
• Treatment Efficacy 6%
• Patients Included 6%
• Treatment Options 6%
• Functional Impairment 6%
• Clinical Criteria 6%
• Combination of Symptoms 6%
• Gait Impairment 6%
• Injection Site Reaction 6%
• Immunoglobulin Therapy 6%
• Patient Concerns 6%
• Hyperexcitability 6%
• Prospective Controlled Study 6%
• Treatment Durability 6%
• Axial Stiffness 6%
• Axial Rigidity 6%
• Limb Stiffness 6%

Medicine and Dentistry

• Immunoglobulin 100%
• Stiff Person Syndrome 100%
• Symptom 15%
• Side Effect 10%
• Muscle Spasm 10%
• Infusion 5%
• Functional Disease 5%
• Limb 5%
• Injection Site Reaction 5%
• Glutamate Decarboxylase 65 Antibody 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Immunoglobulin 100%
• Stiff Man Syndrome 100%
• Symptom 15%
• Side Effect 10%
• Muscle Spasm 10%
• Tolerability 5%
• Functional Disease 5%
• Injection Site Reaction 5%
• Glutamate Decarboxylase 65 Antibody 5%